Registration Options

Register for the meeting.

Session Time and Location

Date: Sunday, 04/24/2022

Time: 3:45 PM (view in the schedule)

Room: TBD

Target Audience

If you are a pharmacist, nurse practitioner or other healthcare professional involved in the comprehensive medication management of psychiatric and/or neurological patients, we invite you to participate in this online course.

Session Summary

Psychiatric pharmacists often encounter patients with substance use disorders in practice. Novel benzodiazepines, including etizolam, clobazolam, and flubromazolam, are potential substances of abuse in the psychiatric patient population. Further knowledge of these novel agents will help psychiatric pharmacists understand, identify, and potentially treat patients with sedative/hypnotic use disorders, or when managing withdrawal symptoms.

Course Requirements

To receive ACPE credit for this session, you must:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Review the full content of the activity and reflect upon its teachings.
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor.
Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information and Disclosures

Kristin Bohnenberger, PharmD, DABAT

View biographical information and disclosures

Learning Objectives

  1. Compare novel benzodiazepines to those commonly prescribed in clinical practice.
  2. Design a monitoring and/or treatment plan for a patient experiencing novel benzodiazepine withdrawal.
  3. Analyze potential interactions between novel benzodiazepines and other substances of abuse or prescription medications.

Continuing Education Credit and Disclosures

Activity Date: 04/24/2022
ACPE Contact Hours: 1
ACPE Number: 0284-0000-22-033-L01-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.